Correction to: A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C
-
Published:2023-03-26
Issue:4
Volume:91
Page:301-301
-
ISSN:0344-5704
-
Container-title:Cancer Chemotherapy and Pharmacology
-
language:en
-
Short-container-title:Cancer Chemother Pharmacol
Author:
Kim RichardORCID,
Leal Alexis D.,
Parikh Aparna,
Ryan David P.,
Wang Shining,
Bahamon Brittany,
Gupta Neeraj,
Moss Aaron,
Pye Joanna,
Miao Harry,
Inguilizian Haig,
Cleary James M.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology